by CheckRare Staff | Aug 3, 2023
Vera Bril, MD, Professor of Medicine at the University of Toronto discusses the recent approval rozanolixizumab to treat myasthenia gravis. Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by weakness of the skeletal...
by CheckRare Staff | Aug 2, 2023
Vera Bril, MD, Professor of Medicine at the University of Toronto discusses rozanolixizumab’s treatment mechanism to treat myasthenia gravis. Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by weakness of the skeletal...
by CheckRare Staff | Aug 1, 2023
Scott Schobel, MD, Chief Medical Officer at Vico Therapeutics, discusses current treatment options for Huntington’s disease and spinocerebellar ataxia (SCA1 and SCA3). Huntington’s disease is a rare neurodegenerative disorder characterized by...
by CheckRare Staff | Jul 31, 2023
Binod Dhakal, MD, Associate Professor at the Medical College of Wisconsin discusses current treatment options for patients with refractory or relapsed multiple myeloma. Multiple myeloma is a rare blood cancer associated with uncontrolled growth of plasma...
by CheckRare Staff | Jul 30, 2023
WHIM syndrome is a rare, congenital primary immunodeficiency disorder associated with neutropenia that typically presents in childhood or adolescence, predominantly caused by pathogenic variants in the CXCR4 chemokine receptor gene.[1] The CXCR4 receptor is involved...
